Biblio

Export 6 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Phenotype  [Clear All Filters]
1997
Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ.  1997.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.. J Cell Biol. 137(1):231-45.
2003
Unger M, Weaver VM.  2003.  The tissue microenvironment as an epigenetic tumor modifier.. Methods Mol Biol. 223:315-47.
2005
Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D et al..  2005.  Tensional homeostasis and the malignant phenotype.. Cancer Cell. 8(3):241-54.
2009
Engler AJ, Humbert PO, Wehrle-Haller B, Weaver VM.  2009.  Multiscale modeling of form and function.. Science. 324(5924):208-12.
2010
Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KKC et al..  2010.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.. J Clin Invest. 120(5):1535-50.
2013
Tang Y, R Rowe G, Botvinick EL, Kurup A, Putnam AJ, Seiki M, Weaver VM, Keller ET, Goldstein S, Dai J et al..  2013.  MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis.. Dev Cell. 25(4):402-16.